Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
Date:8/4/2011

he U.S. Food and Drug Administration (FDA) approved Cumberland's supplemental new drug application (sNDA) for a new formulation of Acetadote, which was the result of a phase IV commitment the Company made to the FDA upon receipt of initial marketing approval of the product. The new formulation does not contain Ethylene diamine tetracetic acid or any other stabilization and chelating agents and is free of preservatives. Cumberland launched the next generation product, which replaced the previously marketed formulation, in the first quarter of 2011 and during the second quarter worked to ensure widespread distribution and transition to the next generation product.

In July 2011, Cumberland filed a response with the U.S. Patent and Trademark Office for its patent application to protect proprietary discoveries related to the new Acetadote formulation. This formulation patent was allowed and issued in China in April 2011. The Company also recently filed a second U.S. patent application related to the safety profile of the new formulation.

sNDA for Non-Acetaminophen Induced Acute Liver Failure

In the first quarter of 2010, Cumberland submitted an application to the FDA for use of Acetadote in patients with non-acetaminophen acute liver failure. This sNDA included data from a clinical trial led by investigators at the University of Texas Southwestern Medical Center indicating that early-stage acute liver failure patients treated with Acetadote have a significantly improved chance of survival without a transplant and that these patients can also survive a significant number of days longer without transplant. In December 2010, the FDA issued a Complete Response Letter indicating that it had identified additional items that must be addressed prior to any approval.

Cumberland has been in discussions with the FDA to determine a pathway forward for the potential new indication. The Company recently identified and is currently analyzing addition
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Zynerba Pharmaceuticals, Inc. ... Form S-1 with the U.S. Securities and Exchange Commission (SEC) ... stock. The number of shares to be offered and the ... Jefferies LLC and Piper Jaffray & ... and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. will ...
(Date:6/30/2015)... SACRAMENTO, Calif. , June 30, 2015 A ... estimate California,s exposure to high-priced Hepatitis ... even if only 5 percent of Californians infected with Hepatitis ... at the costly impact of new Hepatitis C treatments on ... agencies grapple with hefty price tags for drugs like Gilead ...
(Date:6/30/2015)... TAMPA, Fla. , June 30, 2015  Today, ... four winners of the 2015 National Mobility Awareness Month ... with 914 Local Hero online entries that received 1.3 ... are Chrysler , Toyota Mobility , and ... by BraunAbility and Vantage Mobility International ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... 4, 2012 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the 30th ... 2012 at 8:30am PST at The Westin St. Francis ... Pharmaceuticals, Inc. Founded in 2008, Omthera Pharmaceuticals, Inc. ...
... DES MOINES, Iowa, Jan. 4, 2012  Pharmaceutical marketers who ... spending to maximize ROI have limitless questions. ... optimization methodology developed by RMi with a patent-pending ... hoc reporting to help brand leaders find answers. ...
Cached Medicine Technology:Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in California ... event in San Diego. Speakers and clean air advocates included San Diego County Supervisor ... of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... today that they have been awarded the exclusive billing agreements with Jackson Radiology ... of billing services encompassing their proprietary suite of billing process software functionality called ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... June 30, 2015 , ... Family ... of Colorado's Education Symposium on November 9, 2015 at the Hyatt Regency Denver ... a conversation with Kim and Ashley Campbell, the wife and daughter of singer ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM ... team and added a new CEO, Mr. Darold Francis. The changes will help enhance ... essential oils that customers have come to know and respect for over eight years. ...
Breaking Medicine News(10 mins):Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... 10, 2010) - The Massachusetts Eye and Ear ... awarded a grant renewal from the National Institutes of ... support first-rate clinician scientists to promote translational and clinical ... NEI renewed a five-year K12 grant to Mass. Eye ...
... 135th Commencement ... ... at the 135th Commencement ceremony for Meharry Medical College on May 22. Commencement ... open at 11:30 a.m., , , , ,Congressman Clyburn is the Majority Whip in the U.S. ...
... nearly tripled in one year, study finds , MONDAY, May ... is gaining popularity in western countries, and those most likely ... their parents, a new study finds. , Young adults in ... to 20-year-old, English-speaking males who live away from their parents ...
... better supportive care helped push the survival for children ... years after diagnosis, according to new research led by ... the medical journal The Lancet Oncology . The ... than previously reported U.S. rates and is similar to ...
... localized cancer, more conservative treatment may be warranted, study finds ... does not seem to extend the life of elderly people ... finds. , Instead, it suggests, people with such cancer should ... their kidneys. , Kidney cancer cases have increased over ...
... ... À la Carte and Packaged Options Including Publishing, Distribution to Major ... and Specialized Radio Media Tour for Sell-Through,“As the publishing industry has ... authors are opting for self-publishing, but they don’t have the marketing ...
Cached Medicine News:Health News:Mass. Eye and Ear receives NEI grant renewal for 'growing' clinical/scientists 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 3Health News:Hookahs an Unhealthy Hit Among Privileged Young Adults 2Health News:Hookahs an Unhealthy Hit Among Privileged Young Adults 3Health News:Smarter use of existing treatment helps dramatically boost survival of young AML patients 2Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 2Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 3Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 4Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 5Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: